Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-02 Sale | 2024-01-04 5:23 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 2,004 | $20 | $40,080 | 51,831 (Direct) | View |
| 2023-06-07 Sale | 2023-06-09 4:05 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 4,049 | $20.04 | $81,142 | 59,392 (Direct) | View |
| 2022-12-16 Sale | 2022-12-16 9:44 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 2,453 | $30.75 | $75,430 | 11,566 (Direct) | View |
| 2021-12-16 Sale | 2021-12-20 4:22 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 1,106 | $40.12 | $44,376 | 7,019 (Direct) | View |
| 2020-09-09 Purchase | 2020-09-09 4:53 pm | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 5,000 | $21.57 | $107,849 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-23 Option Award(A) | 2024-02-23 5:49 pm | N/A N/A | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 22,000 | $0 | 73,831 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 7:40 pm | N/A 2034-01-22 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 107,900 | $0 | 159,731 (Direct) | View |
| 2023-12-19 Disposition | 2023-12-20 4:10 pm | N/A N/A | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 2,808 | $18.09 | 53,835 (Direct) | View |
| 2023-12-18 Disposition | 2023-12-20 4:10 pm | N/A N/A | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 2,749 | $17.74 | 53,835 (Direct) | View |
| 2023-01-23 Option Award | 2023-01-25 5:53 pm | N/A 2033-01-22 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 172,200 | $0 | 201,641 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-10 5:08 pm | N/A 2032-03-07 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 78,000 | $0 | 85,019 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-20 4:10 pm | N/A 2031-01-18 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 87,500 | $0 | 92,500 (Direct) | View |
| 2020-08-03 Option Award | 2020-08-04 6:53 pm | N/A 2030-07-31 | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 250,000 | $0 | 250,000 (Direct) | View |
Ownership | 2020-08-04 6:15 pm | N/A N/A | Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
| 2020-06-22 Tax Withholding | 2020-06-24 5:03 pm | N/A N/A | Unity Biotechnology Inc. | UBX | Goeltz II Robert C. Chief Financial Officer | 2,483 | $9.67 | 161,027 (Direct) | View |
| 2020-03-30 Option Award | 2020-04-01 5:16 pm | N/A 2030-03-29 | Unity Biotechnology Inc. | UBX | Goeltz II Robert C. Chief Financial Officer | 147,294 | $0 | 281,698 (Direct) | View |
| 2020-02-24 Exercise | 2020-02-26 5:48 pm | N/A N/A | Unity Biotechnology Inc. | UBX | Goeltz II Robert C. Chief Financial Officer | 10,000 | $3.43 | 245,024 (Direct) | View |
| 2020-02-24 Exercise | 2020-02-26 5:48 pm | N/A 2027-09-26 | Unity Biotechnology Inc. | UBX | Goeltz II Robert C. Chief Financial Officer | 10,000 | $0 | 245,024 (Direct) | View |
| 2019-09-19 Option Award | 2019-09-23 8:01 pm | 2019-09-19 2027-09-25 | Unity Biotechnology Inc. | UBX | Goeltz II Robert C. Chief Financial Officer | 28,814 | $0 | 153,218 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:17 pm | N/A 2029-06-19 | Unity Biotechnology Inc. | UBX | Goeltz II Robert C. Chief Financial Officer | 137,925 | $0 | 241,254 (Direct) | View |